139 related articles for article (PubMed ID: 822408)
1. Electroencephalogram and ergot alkaloids.
Venn RD
Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
[No Abstract] [Full Text] [Related]
2. [Determinants estimating cerebral functions after long term therapy with hydergin].
Herzfeld U; Christian W; Ronge J; Wittgen M
Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
[No Abstract] [Full Text] [Related]
3. Pharmacological aspects of dihydrogenated ergot alkaloids in experimental brain research.
Meier-Ruge W; Emmenegger H; Enz A; Gygax P; Iwangoff P; Wiernsperger N
Pharmacology; 1978; 16 Suppl 1():45-62. PubMed ID: 205890
[No Abstract] [Full Text] [Related]
4. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
Loew DM; Jaton AL; Vigouret JM
Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
[No Abstract] [Full Text] [Related]
5. [On the encephalotrophic action of hydergine. Clinical study].
Garagnani Sciarretta B; Rimondini S; Martelli A
Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
[No Abstract] [Full Text] [Related]
6. Experimental studies on the action of metabolic and vasoactive substances in the brain.
Gygax P; Hunziker O; Schulz U; Schweizer A
Triangle; 1975; 14(2):80-9. PubMed ID: 812223
[No Abstract] [Full Text] [Related]
7. The effect of dihydroergotoxin, phentolamine and pindolol on catecholamine-stimulated adenylcyclase in rat cerebral cortex.
Markstein R; Wagner H
FEBS Lett; 1975 Jul; 55(1):275-7. PubMed ID: 806479
[No Abstract] [Full Text] [Related]
8. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
[No Abstract] [Full Text] [Related]
9. Neuropharmacological studies on hydergine.
Depoortere H; Loew DM; Vigouret JM
Triangle; 1975; 14(2):73-9. PubMed ID: 812222
[No Abstract] [Full Text] [Related]
10. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
11. [Analysis of the effect of Hydergin in long-term trial. An interdisciplinary study].
Herzfeld U; Christian W; Oswald WD; Ronge J; Wittgen M
Med Klin; 1972 Sep; 67(35):1118-25. PubMed ID: 4627270
[No Abstract] [Full Text] [Related]
12. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
Brüning G
Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
[No Abstract] [Full Text] [Related]
13. Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency.
Kaye C
Bol Asoc Med P R; 1972 Nov; 64(11):301-3. PubMed ID: 4205800
[No Abstract] [Full Text] [Related]
14. Changes in the rat electrocorticogram following administration of two dihydrogenated ergot derivatives.
Carruthers-Jones DI; Depoortere H; Loew DM
Gerontology; 1978; 24 Suppl 1():23-33. PubMed ID: 412729
[TBL] [Abstract][Full Text] [Related]
15. [Acute changes in intracerebral vascular resistance after application of dihydrogenated ergot alkaloids (author's transl)].
Vaupel P; Hutten H
Arzneimittelforschung; 1980; 30(4):598-602. PubMed ID: 6772196
[TBL] [Abstract][Full Text] [Related]
16. [CLINICAL STUDY ON AN ERGOT DERIVATIVE: HYDERGINE].
REBECCHI M; GOTTI A; BENEDETTI L
Gazz Int Med Chir; 1964 Jan; 68():207-11. PubMed ID: 14154380
[No Abstract] [Full Text] [Related]
17. Biochemical and behavioural effects of hypoxic hypoxia in rats: study of the protection afforded by ergot alkaloids.
Boismare F; Le Poncin M; Lefrançois J
Gerontology; 1978; 24 Suppl 1():6-13. PubMed ID: 412730
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
Gerin J
Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
[No Abstract] [Full Text] [Related]
19. [Electroencephalographic findings in cerebral vascular diseases in aged patients and their changes under the influence of sympatholytic (Hydergine) therapy].
Kauchtschischwili GM; Pontiggia M; Zerbi F
Riv Neurol; 1967; 37(3):231-50. PubMed ID: 4965103
[No Abstract] [Full Text] [Related]
20. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
